Form 4: Roivant Sciences Director Melissa Epperly Receives Stock Award

Director Melissa Epperly received 1,702 common shares of Roivant Sciences Ltd. as part of the company's Non-Employee Director Compensation Plan.

Summary

• Melissa Epperly, a director of Roivant Sciences Ltd., reported a transaction on July 23, 2024.
• She acquired 1,702 common shares of Roivant Sciences (ROIV) as part of the company's Non-Employee Director Compensation Plan.
• The shares were awarded at a price of $0.
• Following the transaction, Epperly directly owns 24,263 common shares of Roivant Sciences.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The transaction reflects standard director compensation practices and aligns director interests with shareholders. There are no indications of negative implications.

Positives

• The stock award to a director aligns their interests with those of the shareholders.
• The award is part of a pre-existing compensation plan, suggesting a structured approach to director compensation.

Industry Context

Stock awards are a common component of compensation packages for directors of publicly traded companies, aligning their interests with shareholders and incentivizing them to drive company performance. This practice is widespread across the pharmaceutical and biotechnology industries, where attracting and retaining experienced board members is crucial for strategic guidance and oversight.

Comparison to Industry Standards

• Director compensation packages vary widely across the pharmaceutical industry, depending on company size, performance, and board structure.
• Companies like Pfizer, Johnson & Johnson, and Merck typically offer a mix of cash retainers, stock options, and restricted stock units to their directors.
• The value of these packages can range from $300,000 to over $1 million annually.
• The Roivant Sciences Non-Employee Director Compensation Plan appears to be in line with industry standards, providing a combination of cash and equity-based compensation to its directors.

Stakeholder Impact

• The stock award aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• The award has a minimal impact on employees, customers, suppliers, and creditors.

Key Dates